Health News Editor
GSK Withdraws from BIO, Signaling Major Setback for Lobbying Group
Pharmaceutical company GSK has announced its decision to leave the Biotechnology Innovation Organization (BIO), which is the largest trade group in the biotechnology industry. This move by GSK marks a significant setback for the...
The Impact of Trump’s Return on NIH Funding and Politicization: What to Expect
After Donald Trump's election win, National Institutes of Health director Monica Bertagnolli addressed the agency's employees, emphasizing the organization's long-standing commitment to biomedical research for public health. Despite reassurances from the NIH, concerns are...
Navigating the Corporate Ladder: Recent Changes and Updates in the Industry
The pharmaceutical industry is always buzzing with changes and updates, and it's important to stay in the loop. Whether a new hire, promotion, or an exciting development, sharing news about who is coming and...
RFK Jr. Seeks Public Input for Trump’s Health Team Selection
President-elect Donald Trump and his team face the daunting task of appointing 4,000 individuals to staff his administration before Inauguration Day. Robert F. Kennedy Jr., a Trump campaign surrogate and advocate for "Make America...
Navigating Trans Health Care in the Trump Administration: Challenges and Strategies
President-elect Donald Trump's campaign targeted transgender individuals, spending significant funds on anti-trans ads. He criticized gender-affirming care for young trans people, calling it "left-wing gender insanity" and "child abuse." Now, as he prepares to...
Inside the Therapist’s Room: A Look at the 2024 Election
I stand before my bathroom mirror, trying to calm my breathing. It's the morning after the election, and I just found out the results an hour ago. I've rushed through my morning routine, feeling...
Seminal Moment for Science Journalism: A Letter from the Executive Editor
Dear Readers,I have written to you before to talk about the importance of subscribing to STAT for our comprehensive coverage of health and medicine. Today, I feel compelled to reiterate this message as we...
Impact of Trump Presidency on FDA, Biotech Industry, and Stock Market
In this week's episode of “The Readout LOUD,” the biotech podcast from STAT, we explore the potential impacts of the Trump presidency on the FDA, the biotech industry, and the stock market. To delve...
Biotech Outlook Post-Trump Presidency: What’s Next?
Adam: Hey Matt, glad you could join me today. The future of the biotech industry post-Trump presidency is something that many are curious about. One key aspect that everyone is keeping an eye on...
Sutter Health CEO Donates to Harris in Wake of Antitrust Investigation
Sutter Health's CEO, Warner Thomas, recently made significant donations to Vice President Harris' presidential campaign and the Democratic National Committee. Despite Harris' involvement in an antitrust investigation against Sutter Health in the past, Thomas...
Interview with FDA’s Top Vaccine Regulator: Addressing Disinformation
The vaccination policy in the United States may be facing some significant changes, especially if Donald Trump is reelected and follows through on promises made by vaccine skeptic Robert Kennedy Jr. However, amidst concerns...
Private Medicare Plans vs VA Care for Veterans: Billions Collected for Services Provided
Many private Medicare insurers are targeting veterans with plans that claim to enhance their Veterans Affairs coverage. These plans, such as the "Patriot Plan," "Courage MA," and "Honor" plan, offer additional benefits like dental...
